The serological response in burros and horses to the viable LVS strain of Pasteurella tularensis was studied. High-titered agglutinating antisera and fluorescentantibody conjugates were obtained in both groups 
Bacterial antisera used in diagnostic laboratories have traditionally been produced in small laboratory animals. Although antisera prepared in these animals are very satisfactory, they are expensive to produce in large quantities. Large animals, particularly horses, have been used for preparing therapeutic and prophylactic bacterial antitoxins and antisera (5, 8) . However, very little attention has been directed towards the use of large animals for producing bacterial diagnostic reagents. Bowmer (1) prepared in horses the international standards for Clostridium botulinum antitoxins which are used for the standardization of therapeutic and diagnostic antitoxins. Harrell et al. (4) prepared antitoxins in horses against the six types of C. botulinum. The latter antisera are used only as diagnostic reagents.
This paper describes the preparation of Pasteurella tularensis antisera in burros and horses. The effect of different primary vaccination schedules, the effect of vaccine with and without adjuvants, and the effect of booster doses of antigens given at intervals after the primary vaccination of the animals were studied.
MATERIALS AND The highest dilution that gave a 3+ to 4+ staining reaction was considered the end point.
Conjugates prepared from the final bleeding of the burros were evaluated for nonspecific staining by using KB tissue culture cells. The method described by Pittman et al. (7) Two different vaccination schedules were used for inoculation of the horses. In schedule I, three horses were inoculated intramuscularly (im) with 10 cells in saline on day zero, followed by 1010 cells in saline im on day seven; two additional horses were inoculated by schedule I with the vaccine suspended in Woodhour's adjuvant (9) . In schedule IL, three horses were inoculated im with 101 cells in saline followed by four im inoculations of 1010 cells in saline at seven-day intervals; three additional horses were inoculated by schedule II with the vaccine suspended in Woodhour's adjuvant. The im inoculations were equally distributed in the large muscles of the four legs.
The horses were given the first booster inoculations 100 days after the last primary inoculation. Several routes of inoculation and concentrations of cells were used. Five of the horses were given a second booster inoculation 268 to 338 days after the first one. The schedule of the booster doses is given in Table 2 . Test bleedings were taken at weekly intervals during the primary vaccination series and at three or four day intervals after the booster inoculations. Conjugates prepared from the final bleedings of the burros were also evaluated for nonspecific staining by using KB tissue-culture cells (7) .
Staining intensities varied from4 + with undiluted conjugates to negative at a 1:32 dilution of the conjugates. Thus, although these conjugates were not evaluated on clinical material containing P. tularensis, the above data suggest that, if they were used at a dilution of 1:32 or higher, there should be no significant nonspecific staining of clinical specimens.
P. tularensis antisera prepared in horses. Eleven horses were inoculated with the live LVS strain by either schedule I or II (see above). The maximum agglutinin and FA titers were obtained on each animal 14 to 21 days after the start of vaccination ( Table 3 ). The maximum agglutinin titers of individual animals varied from 1:256 to 1:1,024; the maximum FA titers varied from 1:80 to 1:360.
All of the animals were given booster inoculations, without adjuvant, 100 days after the primary inoculation; in addition, five of these animals were given a second booster inoculation without adjuvant 268 to 338 days after the first one (Table 2) . No significant increase in agglutinin or FA titer over that obtained during the primary vaccination was noticed in any of the animals after the first or second booster dose (Table 3) . Within 48 hr after the first booster inoculation, two of the animals died from an apparent toxemia resulting from the large numbers of organisms inoculated.
DISCUSSION
These studies show the feasibility of producing P. tularensis antisera in burros and horses. Good Very poor secondary responses were obtained in horses after both the first and second booster doses of antigen. Five of the animals did not show any increase in agglutinin or FA titer over the immediate prebooster titer. In the other four surviving horses, the agglutinin and FA titers were higher than those of the prebooster period, but not significantly higher than the titers obtained during the primary vaccination. Two of the five animals given booster inoculation of either 2 X 1010 or 2 X 1011 organisms intravenously (iv), and the same number im, died from what appeared to be a general toxemia. The use of these large inocula was predicated on the experience we had with horses 29 and 30. The latter two animals received one inoculation of 2 X 108 organisms im and 2 X 107 organisms iv, respectively. There was no increase in the agglutinin or FA titer over those of the prebooster period for either animal (Tables   2 and 3 ).
Nutter (6) recently reported on the vaccination of rabbits with the viable LVS strain of P. tularensis. He did not report FA titers, but the agglutinin response in rabbits with the iv route of inoculation was comparable to those we obtained in equines with either the sc or im route of inoculation. Our results were also similar to those obtained by Nutter (6) , in that a short vaccination schedule was the optimum method of vaccination and booster inoculations did not result in a higher antibody response than was obtained after the primary vaccination.
FA titers of 1: 80 to 1: 320 were obtained from all of the animals during or after the primary vaccination. These are comparable to the FA titers obtained by Yager et al. (10) in roosters after iv inoculation of the live SCHU S-4 strain.
From these results, it is apparent that either burros or horses can be used for the preparation of P. tularensis FA or agglutinin antisera. When one considers a yield of 12 to 15 liters of antiserum from each average size horse and 2 to 3 liters from an average size burro, the advantages of using these animals for large-scale production are obvious. An additional advantage when using the live LVS strain is the short vaccination schedule. However, it is questionable whether equines can be used to prepare antisera against all bacteria. In our own laboratory, for example, we found that horses vaccinated with a killed P. pestis antigen gave very poor quality FA antisera, although good agglutinin antisera were obtained. Other investigators have reported similar results after the vaccination of horses with P. pestis (5) .
